SlideShare uma empresa Scribd logo
1 de 61
APPROACH TO HEMOLYTIC ANEMIA
Dr NAGLAA MAKRAM
CONSULTANT CLINICAL PATHOLOGY
OBJECTIVES
 Lab indication of hemolysis
 Intravascular v/s extravascular hemolysis
 D/D of hemolytic anemia
 Diagnose hemo. anemia with peripheral smear &
ancillary lab tests
1ST STEP IN APPROACH TO HAEMOLYTIC
ANEMIA
1. Check the reticulocyte count to determine if the
anemia is from decreased production
(“hypoproliferative”, “reticulocytopenic”) or
increased destruction (“hemolytic”)/acute blood loss
(“reticulocytosis”)
3. If the the reticulocyte count is increased-
 Check a direct Coomb’s test
4. Look at the peripheral blood smear to
confirm/support the diagnosis
ANEMIA ALGORITHM, CONTINUED
 Patient with anemia and increased reticulocyte count-
What is the result of a Coomb’s test ??
Extrinsic red cell
defect
Vessel Valve
Toxin
Negative Positive
(autoimmune hemolytic anemia)
Intrinsic red cell
defect
Membrane
Hemoglobin
Cytoplasm
“Warm” “Cold”
Random hemolysis :—
In addition to the death of aging (senescent) red blood cells (RBCs), there is
age-independent RBC destruction (random hemolysis) in normal subjects in
range of less than 0.05 to 0.5 percent per day.
When hemolysis occurs, the degree of anemia is minimized by a
compensatory increase in the secretion of erythropoietin (EPO), which
enhances RBC production.
This response is manifested initially by an increase in the reticulocyte
percentage and absolute reticulocyte count, followed by an increase in
hemoglobin (Hgb) concentration.
HOW IS HEMOLYTIC ANEMIA DIAGNOSED?
Two main principles
 One is to confirm that it is hemolysis
 Two is to determine the etiology
FINDINGS IN HEMOLYTIC ANEMIA
HEMOGLOBIN FROM NORMAL TO SEVERELY REDUCED
MCV USUALLY INCREASED
Reticulocyte count and RPI Increased
Serum Unconjugated Bilirubin Increased
Serum LDH 1: LDH 2 Increased
Serum Haptoglobin Decreased
Urine Hemoglobin Present
Urine Hemosiderin Present
Urine Urobilinogen Increased
Cr 51 labeled RBC life span Decreased
Acid hemolysis test (PNH)
LAB FINDINGS AND INVESTIGATIONS
Assess Iron Overload via :
• Serum iron level is elevated, with saturation as high as
80%.
• ferritin and transferrin – elevated
• Aim: Serum ferritin <1000ng/ml.
 Red cell phenotyping (ideal)–transfusion
Extravascular Intravascular
HEMATOLOGIC
Routine blood film
Reticulocyte count
Bone marrow examination
Polychromatophilia
Erythroid hyperplasia
Polychromatophilia
Erythroid hyperplasia
PLASMA OR SERUM
Bilirubin
Haptoglobin
Plasma hemoglobin
Lactate dehydrogenase
Unconjugated
, Absent
N/
(Variable)
Unconjugated
Absent
(Variable)
URINE
Bilirubin
Hemosiderin
Hemoglobin
+
0
0
+
+
+ severe cases
POLYCHROMATOPHILIC CELLS
CORRECTING RETIC COUNT
Retic Index = Retic % x Patient Hct
Normal Hct
Absolute Retic = Retic % x RBC/mm3
Retic Production Index = Retic Index
Days in circulation
drpa
nkaj
yada
v05
@g
mail.
com
THE KEY TO THE ETIOLOGY OF
HEMOLYTIC ANEMIA
The history
The peripheral blood film
CASE 1
 3 yr old male child presenting with pallor, jaundice,
 Severe pain of long bones, fever
 CBC-anemia ,reticulocytosis , increased WBC
 LAB - LDH -600 (normal upto 200)
S. bilirubin- 5 mg%
PERIPHERAL SMEAR
DIAGNOSIS – OTHER TESTS
SICKLING TEST :
 It should not be performed on infants until they are at least
6 month old because of the presence of hemoglobin F as
the predominant hemoglobin at birth , therefore, this test
may give a false-negative result if performed too early (if
hemoglobin S is <10%).
 Recent blood transfusions, typically within the last three
months of the date of testing, may cause a false-negative
test result .
 False positive results may be due to polycythaemic , high
proteins and a variety of abnormal haemoglobins including
Hb’s I, Bart’s, C-Georgetown, Alexandra and C-Harlem.
 Hemoglobin electrophoresis
 Hemoglobin fractionation by HPLC, the most
frequently used method to screen for hemoglobin
variants, including Hb S .
 Isoelectric focusing, a highly sensitive method that is
often used at large reference laboratories .
CLINICAL FEATURES OF SICKLE
HEMOGLOBINOPATHIES
Condition Clinical
abnorm
Hb level g% MCV,fl Hb
electropho
Sickle cell trait None,rare
painlss
hematuria
normal normal HbS/A:
40/60
Sickle cell
anemia
Vasocclusive
crises,AVN,gal
lstones,
priapism
7-10 80-100 HbS/A:100/0
S/beta0
thalasssemia
Vasoocclusive
Crises,AVN
7-10 60-80 HbS/A-100/0
HbF; 1-10%
S/beta+
thalassemia
Rare crises,
AVN
10-14 70-80 HbS/A:
60/40
HbSC --do--,
retinopathy
10-14 80-100 HbS/A;50/0
HbC;50%
DNA analysis :
This test is used to investigate alterations and mutations in
the genes that produce hemoglobin components.
It may be performed to determine whether someone has
one or two copies of the Hb S mutation or has two different
mutations in hemoglobin genes (e.g., Hb S and Hb C).
Genetic counseling :used for prenatal testing: amniotic fluid
may be tested at 14 to 16 weeks to provide a definitive
answer.
It can also be performed earlier with chorionic villus
sampling.
DIAGNOSIS?
SICKLE THALASSEMIA`
CASE 2
 6 yr old child presenting with severe pallor ,
jaundice growth delay
 Abnormal facies , hepatosplenomegaly+
 h/o recurrent blood transfusions
 CBC-Hb -3gm%, MCV-58FL,
-MCH- 19pg (nl-28-33)
P.S- MICROCYTIC,HYPOCHROMIA with
target cells +
DIAGNOSIS?
TARGET CELLS
Distinguishing thalassaemia minor from IDA
from CBC by applying formulae:
Formula Thal. IDA
MCV  RCC (Mentzer index) <13 >13
MCH  RCC < 3.8 > 3.8
(MCV2  MCH)  100 < 1530 > 1530
MCV – RCC – (Hb  5) – 3.4 < 0 > 0
(MCV2  RDW)  (100xHb) < 65 > 65
RDW-CV% <14.6 >14.6
Comparison of β Thalassemias
Parameter Minor Intermedia Major
Hb 10-13 6-10 2-8
MCV (fl) 60-78 50-70 50-60
MCH (pg) 28-32 22-28 16-22
RDW Normal S. increased Increased
Micro/hypo Film Mild Moderate Severe
Polychromasia V. Little Moderate Marked
Anisocytosis None Moderate Marked
Poikilocytosis None Moderate Marked
Targetting Present Present Present
25
COMPARISON OF BETA THALASSEMIAS
GENOTYPE HGB A HGB A2 HGB F
NORMAL Normal Normal Normal
MINOR 80-95%, 3.5-7.5% 1-5%
INTERMEDIA 0-30% 3.5%-5.5% 20-70%
MAJOR 0 % 3.5 %-
5.5%
90-96 %
DNA analysis for mutations
Globin Chain Testing - determines ratio of globin chains being produced.
ALPHA THALASSEMIAS
disease Hb A
%
HbH % Hb , % MCV,fl
Normal α,α/α,α 97 0 15 90
Thalassemia traits
(genotype α,-/α,α)
90-95 rare 12-13 70-80
HbH (b4) (genotype α,-/-,-) 70-95 5-30 6-10 60-70
Hb Bart (genotype -,-/-,-)
(hydrops fetalis)
0 5-10 Fatal
inutero or
at birth
α+ thalassaemia homozygous (genotype α,-/α,-)
αo thalassaemia heterozygous (genotype α,α/,--)
HB-BART’S
 Is only detected at birth. But then disappears
(WHY???). So diagnosis of alpha thalassemia could
be established at birth directly in comparison of beta
thalassemia.
ALPHA THALASSEMIA WITH BASOPHILIC
STIPPLING
HB-H PREPARATION
Same preparation as
Retic count stain, but
with extended time of
incubation, instead of
15 minutes, 2 hours
incubation is required.
Hydrops Fetalis
The blood film of neonate with hemoglobin Bart’s hydrops fetalis showing
anisocytosis, poikilocytosis and numerous nucleated red blood cells
(NRBC).
CASE 3
 45 yr old male came to OPD in a remote PHC with burning
micturition
 Urine R/M shows numerous pus cells++++
 UTI diagnosed & medical officer gave cotrimoxazole 2 bd X
5days
 1 wk later,pt developed severe pallor,palpitation,jaundice
 Lab- increased LDH, S.BILIRUBIN, RETIC COUNT
 P.S- shows irreg cells like
BLISTER CELLS
HEINZ BODIES
DIAGNOSIS?
 G-6PD DEFICIENCY
 INVESTIGATION-
• Peripheral smear: bite cells , heinz bodies - polychromasia
• G-6PD LEVEL
Quantitative , qualitative , PCR
Patients with acute hemolysis, testing for G6PD deficiency may
be falsely negative because older erythrocytes with a higher
enzyme deficiency have been hemolyzed.
Young erythrocytes and reticulocytes have normal or near-
normal enzyme activity.
Female heterozygotes may be hard to diagnose because of X-
chromosome mosaicism leading to a partial deficiency that will
not be detected reliably with screening tests.
 G6PD deficiency should be considered in neonates who
develop hyperbilirubinemia
Pyruvate Kinase Deficiency
 Deficient ATP production, Chronic
hemolytic anemia
 Inv;
P. Smear: PRICKLE CELLS ( Contracted rbc with
spicules)
Decreased enzyme activity
PRICKLE CELL
CASE 4
 14 YR old female present with anemia, jaundice
 Rt hypochondrial pain
 o/e- vitals stable.pallor+,icterus+,splenomegaly +
 Usg- cholilithiasis
 Lab; elevated LDH, S.Bilirubin , reticulocyte
count MCHC, , RDW decreased Hb, MCV.
 Peripheral smear shows-
hyperdense cells
DIFFERENTIAL DIAGNOSIS
 Hereditary spherocytosis
 Autoimmune hemolytic anemia
 Other diagnostic tests- osmotic fragility
- coombs test
 The acid glycerol lysis test
 Screen family members
The red cell lipid composition regulates the membrane
permeability to glycerol.
The added glycerol slows down the rate of water entry into
the red cells.
Measure the time taken for absorbance of red cell
suspension at 625 nm in glycerol to fall to half of its original
value before glycerol addition (AGLT50)
Also detects autoimmune haemolytic anaemia, hereditary
persistence of fetal haemoglobin, pyruvate kinase deficiency,
severe glucose- 6-phosphate dehydrogenase deficiency,
pregnant women (one-third), chronic renal failure on dialysis
Classification Trait Mild Moderate Severe
Haemoglobin (g/dl) Normal 11–15 8–12 6–8
Reticulocyte count %
Normal
(<3%) 3–6 >6 >10
Bilirubin (μmol/l) <17 17–34 >34 >51
Spectrin* per
erythrocyte (% of
normal) 100 80–100 50–80 40–60
Splenectomy
Not
required
Usually not
necessary
Necessary
before puberty
Necessary –
after 6 years if
possible
Symptoms of HS may appear in the perinatal period:
jaundice is common in the first 2 d of life.
 Some neonates with HS may be transfusion-
dependent(unusual) due to their inability to mount an
adequate erythropoietic response in the first year of life .
Recent evidence suggests that erythropoietin may be of
benefit in reducing or avoiding transfusion, and can usually be
stopped by the age of 9 months .
 Children who require one or two transfusions early in life
frequently become transfusion independent
An artifact showing ‘macrospherocytosis’ on a blood film
can be produced as a result of cold storage of blood
samples from patients with cryohydrocytosis, which is a
variant form of hereditary stomatocytosis (‘atypical HS’)
It is particularly important to rule out stomatocytosis where
splenectomy is contraindicated because of the thrombotic
risk.
Atypical cases may require measurement of erythrocyte
membrane proteins to clarify the nature of the membrane
disorder and in the absence of a family history.
 Occasionally molecular genetic analysis will help to
determine whether inheritance is recessive or non-dominant.
Iron, folate or vitamin B12 deficiencies can mask the
laboratory features.
Obstructive jaundice alters the lipid composition of the
red cell membrane, masking the film appearances and
reducing the haemolysis.
Co-inheritance of other haematological disorders, such
as beta thalassaemia trait or SC disease, can lead to
confusion in the diagnosis and variable clinical effects
.
AUTOIMMUNE HAEMOLYTIC ANAEMIA
 hemolysis, MCV decreased
 P Smear: microspherocytosis,
 Confirmation:
Warm
Direct Coomb’s Test / Antiglobulin test
Cold
DAT positive with polyspecific and anticompliment antisera
DAT
•Sensitivity/Specificity:
>99% patients with warm agglutinin AIHA will exhibit a positive result;
<1% normal population have + result.
In some cases the density of attached
autoantibody may be too low for detection by DAT.
This may be resolved by flow cytometric assessment
of red cell Ig density .
Polyspecific DAT reagents may also fail to detect
some autoantibodies, particularly IgA, as anti-IgA is
not usually incorporated into the reagent.
Application of specific anti G, A, M and
complement DAT reagents may resolve some cases
INSERT TITLE TEXT HERE
MACROCYTE
SPHEROCYTE
IMMUNOHEMOLYTIC ANEMIA
CASE 5
 32 yr old presented 4 days history of distention of
abdomen and rt hypochondrial pain and has h/o
passage of dark colored urine at night for weeks
 On USG- hepatomegaly,gross ascites,hepatic vein
thrombosis
Lab : Hb – 7gm%. WBC- 2200, PLC- 80,000
LDH- 600, S.BR- 4 mg%
urine bile pigment +,heme dip stick++
What is the diagnosis?
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
 Acquired chronic H.A
 Persistent intra vascular hemolysis
 Pancytopenia
 Lab :HBuria,hemosiderinuria,increased LDH,bilirubin
 Risk of venous thrombosis
 C/F – hemoglobinuria during night
 P.S – polychromatophilia, normoblasts
 B.M – normoblastic hyperplasia
 Def.diagnosis-flow cytometry CD59-,CD55- RBC,WBC
Acid haemolysis test
Acid hemolysis test (PNH)A
Caused from a defect in the production of GPI
protein anchors on the surface of all blood cell
Protect red cells from the activity of the
complement system. but 2 are important in
protecting red cells from destruction: CD55 (DAF)
and CD59
Defect makes the red cells in particular
susceptible to destruction by the complement
system. Intravascular hemolytic anemia.
“FOOT STRIKE HEMOLYSIS”
 Caused by RBC destruction from repeated trauma
• Elevated temperature in muscle, turbulence and
acidosis may also be involved
  Bilirubin
  Haptoglobin
  Schistocytes
 Slight  MCV & Reticulocytes
 Preferential breakdown of older rbcs
 Hemoglobinuria
 Anemia resolves w/ d/c exercise
THANK YOU
BETA THALASSEMIA
 Mutn. Beta globin expression
 M.C- derange splicing of m-RNA
 HYPOCHROMIA ,MICROCYTIC anemia
AUTOIMMUNE HEMOLYTIC ANEMIA
 Result from RBC destruction due to RBC
autoantibodies: Ig G, M, E, A
 Most commonly-idiopathic
 Classification
 Warm AI hemolysis:Ab binds at 37 C
 Cold AI Hemolysis: Ab binds at 4 C
1.Warm AI Hemolysis:
 Can occurs at all age groups
 F > M
 Causes:
50% Idiopathic
Rest - secondary causes:
1.Lymphoid neoplasm: CLL, Lymphoma,
Myeloma
2.Solid Tumors: Lung, Colon, Kidney, Ovary,
Thymoma
3.CTD: SLE,RA
4.Drugs: Alpha methyl DOPA, Penicillin ,
Quinine, Chloroquine
5. UC, HIV
Approach to hemolytic anemia naglaa

Mais conteúdo relacionado

Mais procurados

Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
Debra G. Carnahan
 
Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuriaParoxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria
Joselle Balasa
 

Mais procurados (20)

4a..hemolytic anemia
4a..hemolytic anemia4a..hemolytic anemia
4a..hemolytic anemia
 
Pnh
PnhPnh
Pnh
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
 
Approach to hemolytic anemias
Approach to hemolytic anemiasApproach to hemolytic anemias
Approach to hemolytic anemias
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuriaParoxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria
 
Paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria (PNH)Paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria (PNH)
 
Approach to a patient with hemolytic anaemia
Approach to a patient with hemolytic anaemiaApproach to a patient with hemolytic anaemia
Approach to a patient with hemolytic anaemia
 
Anemia
AnemiaAnemia
Anemia
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
 
Hemolytic anemia - Approach and Management
Hemolytic anemia - Approach and ManagementHemolytic anemia - Approach and Management
Hemolytic anemia - Approach and Management
 
Hemolytic anemia ppt presentation
Hemolytic anemia ppt presentationHemolytic anemia ppt presentation
Hemolytic anemia ppt presentation
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
Approach to Hemolytic Anemia
Approach to Hemolytic AnemiaApproach to Hemolytic Anemia
Approach to Hemolytic Anemia
 
Haemolytic anaemia
Haemolytic anaemiaHaemolytic anaemia
Haemolytic anaemia
 
Aiha
AihaAiha
Aiha
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
 
Diagnosis of hemolytic anemia
Diagnosis of hemolytic anemiaDiagnosis of hemolytic anemia
Diagnosis of hemolytic anemia
 
G6PD disease.pptx
G6PD disease.pptxG6PD disease.pptx
G6PD disease.pptx
 
Sickle cell anaemia
Sickle cell anaemiaSickle cell anaemia
Sickle cell anaemia
 

Semelhante a Approach to hemolytic anemia naglaa

cytology of body fluid
 cytology of body fluid cytology of body fluid
cytology of body fluid
Musa Khan
 
Blood & blood products
Blood & blood productsBlood & blood products
Blood & blood products
Laxinys
 
Blood & blood products
Blood & blood productsBlood & blood products
Blood & blood products
Laxinys
 
Blood & Blood Products
Blood & Blood ProductsBlood & Blood Products
Blood & Blood Products
Laxinys
 

Semelhante a Approach to hemolytic anemia naglaa (20)

Hematology analyzer detecting erroneous blood counts
Hematology analyzer  detecting erroneous blood  countsHematology analyzer  detecting erroneous blood  counts
Hematology analyzer detecting erroneous blood counts
 
Hemolytic anemias hemoglobinopathies
Hemolytic anemias   hemoglobinopathiesHemolytic anemias   hemoglobinopathies
Hemolytic anemias hemoglobinopathies
 
laboratory diagnosis of hemolytic anemia-190509145931.pptx
laboratory diagnosis of hemolytic anemia-190509145931.pptxlaboratory diagnosis of hemolytic anemia-190509145931.pptx
laboratory diagnosis of hemolytic anemia-190509145931.pptx
 
cytology of body fluid
 cytology of body fluid cytology of body fluid
cytology of body fluid
 
hemolytic disease of newborn
hemolytic disease of newbornhemolytic disease of newborn
hemolytic disease of newborn
 
thalassemia
thalassemiathalassemia
thalassemia
 
Thalassemia
ThalassemiaThalassemia
Thalassemia
 
hemolytic anemia 1
hemolytic anemia 1hemolytic anemia 1
hemolytic anemia 1
 
LABORATORY APPROACH TO HEMOLYTIC ANEMIAS.pptx
LABORATORY APPROACH TO HEMOLYTIC ANEMIAS.pptxLABORATORY APPROACH TO HEMOLYTIC ANEMIAS.pptx
LABORATORY APPROACH TO HEMOLYTIC ANEMIAS.pptx
 
Laboratory Diagonosis thalassemia Chirantan
Laboratory Diagonosis  thalassemia Chirantan Laboratory Diagonosis  thalassemia Chirantan
Laboratory Diagonosis thalassemia Chirantan
 
LabORATORY daigonosis thalassemia Chirantan Man
LabORATORY  daigonosis thalassemia Chirantan ManLabORATORY  daigonosis thalassemia Chirantan Man
LabORATORY daigonosis thalassemia Chirantan Man
 
Pathogenesis & Lab diagnosis of Hemolytic Anemia
Pathogenesis & Lab diagnosis of Hemolytic AnemiaPathogenesis & Lab diagnosis of Hemolytic Anemia
Pathogenesis & Lab diagnosis of Hemolytic Anemia
 
Thalassemia- Introduction and Diagnosis
Thalassemia- Introduction and DiagnosisThalassemia- Introduction and Diagnosis
Thalassemia- Introduction and Diagnosis
 
Haemoglobinopathies
HaemoglobinopathiesHaemoglobinopathies
Haemoglobinopathies
 
Interpretation of Routine Laboratory investigations in General practice
Interpretation of Routine Laboratory investigations in General practiceInterpretation of Routine Laboratory investigations in General practice
Interpretation of Routine Laboratory investigations in General practice
 
Investigation in hematology
Investigation in hematologyInvestigation in hematology
Investigation in hematology
 
anemia approach
anemia approachanemia approach
anemia approach
 
Blood & blood products
Blood & blood productsBlood & blood products
Blood & blood products
 
Blood & blood products
Blood & blood productsBlood & blood products
Blood & blood products
 
Blood & Blood Products
Blood & Blood ProductsBlood & Blood Products
Blood & Blood Products
 

Mais de Naglaa Makram (6)

Syphalis - final - naglaa MAKRAM
Syphalis  - final  - naglaa  MAKRAM Syphalis  - final  - naglaa  MAKRAM
Syphalis - final - naglaa MAKRAM
 
Chemistry specimen dr naglaa
Chemistry specimen   dr naglaaChemistry specimen   dr naglaa
Chemistry specimen dr naglaa
 
‫Pretransfusion testing final- ab screening - NAGLAA MAKRAM
‫Pretransfusion testing  final- ab screening - NAGLAA MAKRAM ‫Pretransfusion testing  final- ab screening - NAGLAA MAKRAM
‫Pretransfusion testing final- ab screening - NAGLAA MAKRAM
 
Syphalis - final - naglaa
Syphalis  - final  - naglaaSyphalis  - final  - naglaa
Syphalis - final - naglaa
 
Biochemical markers of bone remodeling
Biochemical markers of bone remodelingBiochemical markers of bone remodeling
Biochemical markers of bone remodeling
 
Vit d is it the mericle vitamine
Vit d is it the mericle vitamineVit d is it the mericle vitamine
Vit d is it the mericle vitamine
 

Approach to hemolytic anemia naglaa

  • 1. APPROACH TO HEMOLYTIC ANEMIA Dr NAGLAA MAKRAM CONSULTANT CLINICAL PATHOLOGY
  • 2. OBJECTIVES  Lab indication of hemolysis  Intravascular v/s extravascular hemolysis  D/D of hemolytic anemia  Diagnose hemo. anemia with peripheral smear & ancillary lab tests
  • 3. 1ST STEP IN APPROACH TO HAEMOLYTIC ANEMIA 1. Check the reticulocyte count to determine if the anemia is from decreased production (“hypoproliferative”, “reticulocytopenic”) or increased destruction (“hemolytic”)/acute blood loss (“reticulocytosis”) 3. If the the reticulocyte count is increased-  Check a direct Coomb’s test 4. Look at the peripheral blood smear to confirm/support the diagnosis
  • 4. ANEMIA ALGORITHM, CONTINUED  Patient with anemia and increased reticulocyte count- What is the result of a Coomb’s test ?? Extrinsic red cell defect Vessel Valve Toxin Negative Positive (autoimmune hemolytic anemia) Intrinsic red cell defect Membrane Hemoglobin Cytoplasm “Warm” “Cold”
  • 5. Random hemolysis :— In addition to the death of aging (senescent) red blood cells (RBCs), there is age-independent RBC destruction (random hemolysis) in normal subjects in range of less than 0.05 to 0.5 percent per day. When hemolysis occurs, the degree of anemia is minimized by a compensatory increase in the secretion of erythropoietin (EPO), which enhances RBC production. This response is manifested initially by an increase in the reticulocyte percentage and absolute reticulocyte count, followed by an increase in hemoglobin (Hgb) concentration.
  • 6. HOW IS HEMOLYTIC ANEMIA DIAGNOSED? Two main principles  One is to confirm that it is hemolysis  Two is to determine the etiology
  • 7. FINDINGS IN HEMOLYTIC ANEMIA HEMOGLOBIN FROM NORMAL TO SEVERELY REDUCED MCV USUALLY INCREASED Reticulocyte count and RPI Increased Serum Unconjugated Bilirubin Increased Serum LDH 1: LDH 2 Increased Serum Haptoglobin Decreased Urine Hemoglobin Present Urine Hemosiderin Present Urine Urobilinogen Increased Cr 51 labeled RBC life span Decreased Acid hemolysis test (PNH)
  • 8. LAB FINDINGS AND INVESTIGATIONS Assess Iron Overload via : • Serum iron level is elevated, with saturation as high as 80%. • ferritin and transferrin – elevated • Aim: Serum ferritin <1000ng/ml.  Red cell phenotyping (ideal)–transfusion
  • 9. Extravascular Intravascular HEMATOLOGIC Routine blood film Reticulocyte count Bone marrow examination Polychromatophilia Erythroid hyperplasia Polychromatophilia Erythroid hyperplasia PLASMA OR SERUM Bilirubin Haptoglobin Plasma hemoglobin Lactate dehydrogenase Unconjugated , Absent N/ (Variable) Unconjugated Absent (Variable) URINE Bilirubin Hemosiderin Hemoglobin + 0 0 + + + severe cases
  • 11. CORRECTING RETIC COUNT Retic Index = Retic % x Patient Hct Normal Hct Absolute Retic = Retic % x RBC/mm3 Retic Production Index = Retic Index Days in circulation drpa nkaj yada v05 @g mail. com
  • 12. THE KEY TO THE ETIOLOGY OF HEMOLYTIC ANEMIA The history The peripheral blood film
  • 13. CASE 1  3 yr old male child presenting with pallor, jaundice,  Severe pain of long bones, fever  CBC-anemia ,reticulocytosis , increased WBC  LAB - LDH -600 (normal upto 200) S. bilirubin- 5 mg%
  • 15. DIAGNOSIS – OTHER TESTS SICKLING TEST :  It should not be performed on infants until they are at least 6 month old because of the presence of hemoglobin F as the predominant hemoglobin at birth , therefore, this test may give a false-negative result if performed too early (if hemoglobin S is <10%).  Recent blood transfusions, typically within the last three months of the date of testing, may cause a false-negative test result .  False positive results may be due to polycythaemic , high proteins and a variety of abnormal haemoglobins including Hb’s I, Bart’s, C-Georgetown, Alexandra and C-Harlem.
  • 16.  Hemoglobin electrophoresis  Hemoglobin fractionation by HPLC, the most frequently used method to screen for hemoglobin variants, including Hb S .  Isoelectric focusing, a highly sensitive method that is often used at large reference laboratories .
  • 17. CLINICAL FEATURES OF SICKLE HEMOGLOBINOPATHIES Condition Clinical abnorm Hb level g% MCV,fl Hb electropho Sickle cell trait None,rare painlss hematuria normal normal HbS/A: 40/60 Sickle cell anemia Vasocclusive crises,AVN,gal lstones, priapism 7-10 80-100 HbS/A:100/0 S/beta0 thalasssemia Vasoocclusive Crises,AVN 7-10 60-80 HbS/A-100/0 HbF; 1-10% S/beta+ thalassemia Rare crises, AVN 10-14 70-80 HbS/A: 60/40 HbSC --do--, retinopathy 10-14 80-100 HbS/A;50/0 HbC;50%
  • 18. DNA analysis : This test is used to investigate alterations and mutations in the genes that produce hemoglobin components. It may be performed to determine whether someone has one or two copies of the Hb S mutation or has two different mutations in hemoglobin genes (e.g., Hb S and Hb C). Genetic counseling :used for prenatal testing: amniotic fluid may be tested at 14 to 16 weeks to provide a definitive answer. It can also be performed earlier with chorionic villus sampling.
  • 20. CASE 2  6 yr old child presenting with severe pallor , jaundice growth delay  Abnormal facies , hepatosplenomegaly+  h/o recurrent blood transfusions  CBC-Hb -3gm%, MCV-58FL, -MCH- 19pg (nl-28-33) P.S- MICROCYTIC,HYPOCHROMIA with target cells +
  • 23. Distinguishing thalassaemia minor from IDA from CBC by applying formulae: Formula Thal. IDA MCV  RCC (Mentzer index) <13 >13 MCH  RCC < 3.8 > 3.8 (MCV2  MCH)  100 < 1530 > 1530 MCV – RCC – (Hb  5) – 3.4 < 0 > 0 (MCV2  RDW)  (100xHb) < 65 > 65 RDW-CV% <14.6 >14.6
  • 24. Comparison of β Thalassemias Parameter Minor Intermedia Major Hb 10-13 6-10 2-8 MCV (fl) 60-78 50-70 50-60 MCH (pg) 28-32 22-28 16-22 RDW Normal S. increased Increased Micro/hypo Film Mild Moderate Severe Polychromasia V. Little Moderate Marked Anisocytosis None Moderate Marked Poikilocytosis None Moderate Marked Targetting Present Present Present
  • 25. 25 COMPARISON OF BETA THALASSEMIAS GENOTYPE HGB A HGB A2 HGB F NORMAL Normal Normal Normal MINOR 80-95%, 3.5-7.5% 1-5% INTERMEDIA 0-30% 3.5%-5.5% 20-70% MAJOR 0 % 3.5 %- 5.5% 90-96 % DNA analysis for mutations Globin Chain Testing - determines ratio of globin chains being produced.
  • 26. ALPHA THALASSEMIAS disease Hb A % HbH % Hb , % MCV,fl Normal α,α/α,α 97 0 15 90 Thalassemia traits (genotype α,-/α,α) 90-95 rare 12-13 70-80 HbH (b4) (genotype α,-/-,-) 70-95 5-30 6-10 60-70 Hb Bart (genotype -,-/-,-) (hydrops fetalis) 0 5-10 Fatal inutero or at birth α+ thalassaemia homozygous (genotype α,-/α,-) αo thalassaemia heterozygous (genotype α,α/,--)
  • 27. HB-BART’S  Is only detected at birth. But then disappears (WHY???). So diagnosis of alpha thalassemia could be established at birth directly in comparison of beta thalassemia.
  • 28. ALPHA THALASSEMIA WITH BASOPHILIC STIPPLING
  • 29. HB-H PREPARATION Same preparation as Retic count stain, but with extended time of incubation, instead of 15 minutes, 2 hours incubation is required.
  • 30. Hydrops Fetalis The blood film of neonate with hemoglobin Bart’s hydrops fetalis showing anisocytosis, poikilocytosis and numerous nucleated red blood cells (NRBC).
  • 31. CASE 3  45 yr old male came to OPD in a remote PHC with burning micturition  Urine R/M shows numerous pus cells++++  UTI diagnosed & medical officer gave cotrimoxazole 2 bd X 5days  1 wk later,pt developed severe pallor,palpitation,jaundice  Lab- increased LDH, S.BILIRUBIN, RETIC COUNT  P.S- shows irreg cells like
  • 32.
  • 35. DIAGNOSIS?  G-6PD DEFICIENCY  INVESTIGATION- • Peripheral smear: bite cells , heinz bodies - polychromasia • G-6PD LEVEL Quantitative , qualitative , PCR
  • 36. Patients with acute hemolysis, testing for G6PD deficiency may be falsely negative because older erythrocytes with a higher enzyme deficiency have been hemolyzed. Young erythrocytes and reticulocytes have normal or near- normal enzyme activity. Female heterozygotes may be hard to diagnose because of X- chromosome mosaicism leading to a partial deficiency that will not be detected reliably with screening tests.  G6PD deficiency should be considered in neonates who develop hyperbilirubinemia
  • 37. Pyruvate Kinase Deficiency  Deficient ATP production, Chronic hemolytic anemia  Inv; P. Smear: PRICKLE CELLS ( Contracted rbc with spicules) Decreased enzyme activity
  • 39. CASE 4  14 YR old female present with anemia, jaundice  Rt hypochondrial pain  o/e- vitals stable.pallor+,icterus+,splenomegaly +  Usg- cholilithiasis  Lab; elevated LDH, S.Bilirubin , reticulocyte count MCHC, , RDW decreased Hb, MCV.  Peripheral smear shows- hyperdense cells
  • 40.
  • 41. DIFFERENTIAL DIAGNOSIS  Hereditary spherocytosis  Autoimmune hemolytic anemia  Other diagnostic tests- osmotic fragility - coombs test  The acid glycerol lysis test  Screen family members
  • 42.
  • 43. The red cell lipid composition regulates the membrane permeability to glycerol. The added glycerol slows down the rate of water entry into the red cells. Measure the time taken for absorbance of red cell suspension at 625 nm in glycerol to fall to half of its original value before glycerol addition (AGLT50) Also detects autoimmune haemolytic anaemia, hereditary persistence of fetal haemoglobin, pyruvate kinase deficiency, severe glucose- 6-phosphate dehydrogenase deficiency, pregnant women (one-third), chronic renal failure on dialysis
  • 44. Classification Trait Mild Moderate Severe Haemoglobin (g/dl) Normal 11–15 8–12 6–8 Reticulocyte count % Normal (<3%) 3–6 >6 >10 Bilirubin (μmol/l) <17 17–34 >34 >51 Spectrin* per erythrocyte (% of normal) 100 80–100 50–80 40–60 Splenectomy Not required Usually not necessary Necessary before puberty Necessary – after 6 years if possible
  • 45.
  • 46. Symptoms of HS may appear in the perinatal period: jaundice is common in the first 2 d of life.  Some neonates with HS may be transfusion- dependent(unusual) due to their inability to mount an adequate erythropoietic response in the first year of life . Recent evidence suggests that erythropoietin may be of benefit in reducing or avoiding transfusion, and can usually be stopped by the age of 9 months .  Children who require one or two transfusions early in life frequently become transfusion independent
  • 47. An artifact showing ‘macrospherocytosis’ on a blood film can be produced as a result of cold storage of blood samples from patients with cryohydrocytosis, which is a variant form of hereditary stomatocytosis (‘atypical HS’) It is particularly important to rule out stomatocytosis where splenectomy is contraindicated because of the thrombotic risk. Atypical cases may require measurement of erythrocyte membrane proteins to clarify the nature of the membrane disorder and in the absence of a family history.  Occasionally molecular genetic analysis will help to determine whether inheritance is recessive or non-dominant.
  • 48. Iron, folate or vitamin B12 deficiencies can mask the laboratory features. Obstructive jaundice alters the lipid composition of the red cell membrane, masking the film appearances and reducing the haemolysis. Co-inheritance of other haematological disorders, such as beta thalassaemia trait or SC disease, can lead to confusion in the diagnosis and variable clinical effects .
  • 49. AUTOIMMUNE HAEMOLYTIC ANAEMIA  hemolysis, MCV decreased  P Smear: microspherocytosis,  Confirmation: Warm Direct Coomb’s Test / Antiglobulin test Cold DAT positive with polyspecific and anticompliment antisera
  • 50. DAT •Sensitivity/Specificity: >99% patients with warm agglutinin AIHA will exhibit a positive result; <1% normal population have + result.
  • 51. In some cases the density of attached autoantibody may be too low for detection by DAT. This may be resolved by flow cytometric assessment of red cell Ig density . Polyspecific DAT reagents may also fail to detect some autoantibodies, particularly IgA, as anti-IgA is not usually incorporated into the reagent. Application of specific anti G, A, M and complement DAT reagents may resolve some cases
  • 52. INSERT TITLE TEXT HERE MACROCYTE SPHEROCYTE IMMUNOHEMOLYTIC ANEMIA
  • 53. CASE 5  32 yr old presented 4 days history of distention of abdomen and rt hypochondrial pain and has h/o passage of dark colored urine at night for weeks  On USG- hepatomegaly,gross ascites,hepatic vein thrombosis Lab : Hb – 7gm%. WBC- 2200, PLC- 80,000 LDH- 600, S.BR- 4 mg% urine bile pigment +,heme dip stick++ What is the diagnosis?
  • 54. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA  Acquired chronic H.A  Persistent intra vascular hemolysis  Pancytopenia  Lab :HBuria,hemosiderinuria,increased LDH,bilirubin  Risk of venous thrombosis  C/F – hemoglobinuria during night  P.S – polychromatophilia, normoblasts  B.M – normoblastic hyperplasia  Def.diagnosis-flow cytometry CD59-,CD55- RBC,WBC Acid haemolysis test Acid hemolysis test (PNH)A
  • 55. Caused from a defect in the production of GPI protein anchors on the surface of all blood cell Protect red cells from the activity of the complement system. but 2 are important in protecting red cells from destruction: CD55 (DAF) and CD59 Defect makes the red cells in particular susceptible to destruction by the complement system. Intravascular hemolytic anemia.
  • 56. “FOOT STRIKE HEMOLYSIS”  Caused by RBC destruction from repeated trauma • Elevated temperature in muscle, turbulence and acidosis may also be involved   Bilirubin   Haptoglobin   Schistocytes  Slight  MCV & Reticulocytes  Preferential breakdown of older rbcs  Hemoglobinuria  Anemia resolves w/ d/c exercise
  • 58. BETA THALASSEMIA  Mutn. Beta globin expression  M.C- derange splicing of m-RNA  HYPOCHROMIA ,MICROCYTIC anemia
  • 59. AUTOIMMUNE HEMOLYTIC ANEMIA  Result from RBC destruction due to RBC autoantibodies: Ig G, M, E, A  Most commonly-idiopathic  Classification  Warm AI hemolysis:Ab binds at 37 C  Cold AI Hemolysis: Ab binds at 4 C
  • 60. 1.Warm AI Hemolysis:  Can occurs at all age groups  F > M  Causes: 50% Idiopathic Rest - secondary causes: 1.Lymphoid neoplasm: CLL, Lymphoma, Myeloma 2.Solid Tumors: Lung, Colon, Kidney, Ovary, Thymoma 3.CTD: SLE,RA 4.Drugs: Alpha methyl DOPA, Penicillin , Quinine, Chloroquine 5. UC, HIV